William Blair Has Bearish Estimate for Avantor Q1 Earnings

Avantor, Inc. (NYSE:AVTR) – Equities research analysts at William Blair reduced their Q1 2025 earnings estimates for shares of Avantor in a research note issued to investors on Monday, February 10th. William Blair analyst M. Larew now forecasts that the company will earn $0.22 per share for the quarter, down from their previous forecast of $0.24. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. William Blair also issued estimates for Avantor’s Q2 2025 earnings at $0.26 EPS, Q4 2025 earnings at $0.30 EPS, FY2025 earnings at $1.07 EPS, Q1 2026 earnings at $0.27 EPS, Q2 2026 earnings at $0.30 EPS, Q3 2026 earnings at $0.31 EPS, Q4 2026 earnings at $0.35 EPS and FY2026 earnings at $1.23 EPS.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same period in the prior year, the firm earned $0.22 EPS.

A number of other brokerages have also recently commented on AVTR. Wells Fargo & Company decreased their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday. UBS Group reiterated a “neutral” rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Raymond James restated an “outperform” rating and set a $24.00 target price (down from $26.00) on shares of Avantor in a report on Monday. Robert W. Baird decreased their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Finally, Stifel Nicolaus lowered their price objective on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $26.15.

Avantor Trading Down 3.1 %

Shares of AVTR stock opened at $18.42 on Wednesday. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The firm has a market cap of $12.53 billion, a P/E ratio of 40.03, a price-to-earnings-growth ratio of 3.87 and a beta of 1.28. The business has a 50-day moving average price of $21.68 and a two-hundred day moving average price of $23.44. Avantor has a 12-month low of $18.19 and a 12-month high of $28.00.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in AVTR. Public Employees Retirement System of Ohio raised its holdings in Avantor by 34.1% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock worth $8,972,000 after acquiring an additional 88,205 shares during the last quarter. Perpetual Ltd increased its holdings in shares of Avantor by 38.7% in the 4th quarter. Perpetual Ltd now owns 1,766,882 shares of the company’s stock worth $37,228,000 after purchasing an additional 493,408 shares in the last quarter. New York State Teachers Retirement System purchased a new position in shares of Avantor in the third quarter worth $8,473,000. Everence Capital Management Inc. bought a new position in shares of Avantor during the fourth quarter valued at $555,000. Finally, Teachers Retirement System of The State of Kentucky boosted its position in shares of Avantor by 45.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 723,178 shares of the company’s stock valued at $18,708,000 after buying an additional 227,200 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.